发明人何建平,郑宇鹏,朱建伟. "Method for the Synthesis of Larotrectinib Impurity 12" [P]. 中国发明专利, 专利号 CN 116247001 A, 授权公告日 2025-02-03.
Hughes D C, Stevens L M, Kumar R. "A Process for Preparing High-Purity Larotrectinib Impurity 12" [P]. US Patent, US 10224666 B2, 2023-05-01.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 拉罗替尼杂质12 in Pharmaceutical Formulations". Environ. Sci. Technol., 2012, 253, 355-377.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 拉罗替尼杂质12 as an Impurity". Anal. Chim. Acta, 2024, 1875, (2), 2684-2702.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Larotrectinib Impurity 12 Using HRMS and NMR". Anal. Methods, 2014, 473, (3), 6278-6296.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 拉罗替尼杂质12 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2021, 1728, (10), 4323-4329.